Atlas Trials

Phase 1

65,473 clinical trials · Phase

Sort:Newest firstOldest first

◉ Watch Phase 1

RecordFirmDate
Bioequivalence Study Of PHENYTOIN Suspension Made By Pfizer, Versus EPAMIN® Made By McNeil LA LLC In Healthy Volunteers Under Fasting Conditions (NCT01122953)Pfizer's Upjohn has merged with Mylan to form Viatris Inc.2010-04-01
Assessment of Combined Bowel Preparation for Capsule Endoscopy Study (NCT01243736)Mayo Clinic2010-04-01
Transdermal Absorption of Dimercaptopropane-1-Sulfonate (DMPS) and Effect on Urinary Mercury Excretion (NCT01059474)Banner Health2010-04-01
A Study in Myeloproliferative Disorders (NCT01134120)Eli Lilly and Company2010-04-01
Arsenic Trioxide With or Without Ascorbic Acid in Treating Patients With Myelofibrosis (NCT01014546)Roswell Park Cancer Institute2010-04-01
Clofarabine in High Risk Myelodysplastic Syndrome (MDS) (NCT01063257)Groupe Francophone des Myelodysplasies2010-04-01
Investigate the Effect of AZD1656 on the Pharmacokinetics and Pharmacodynamics of Warfarin in Type 2 Diabetes Mellitus (T2DM) Patients (NCT01103609)AstraZeneca2010-04-01
Remote Ischemic Preconditioning in Subarachnoid Hemorrhage (NCT01158508)University of California, Los Angeles2010-04-01
A Study Combining ABT-888, Oral PARP Inhibitor, With Temozolomide in Patients With Metastatic Prostate Cancer (NCT01085422)AbbVie (prior sponsor, Abbott)2010-04-01
Phase 1-2 of Temozolomide and Hypofractionated Radiotherapy in Tx of Supratentorial Glioblastoma Multiform (NCT01120639)Stanford University2010-04-01
Pharmacotoxicology of Trichloroethylene Metabolites (NCT01128270)University of Florida2010-04-01
A Pilot Study to Evaluate Safety and Efficacy of CigRx™ in Smokers (NCT01262170)Rock Creek Pharmaceuticals, Inc.2010-04-01
Prevention Trial Assessing Paper-Tape in Endurance Distances (PreTAPED) (NCT01120808)Stanford University2010-04-01
Study to Assess Safety, Tolerability and PK of AZD1480 in Patients With Solid Tumours (NCT01112397)AstraZeneca2010-04-01
Components of Chlorhexidine Gluconate Dressing (NCT01112020)C. R. Bard2010-04-01
Phase 1b Influenza Vaccine Study in Healthy Subjects (NCT01181336)PepTcell Limited2010-04-01
Intestinal Microecology in Chronic Constipation (NCT00934479)Mayo Clinic2010-04-01
Drug Interaction Study of Avanafil and Enalapril or Amlodipine (NCT01117038)VIVUS LLC2010-04-01
MK0752 and Gemcitabine Hydrochloride in Treating Patients With Stage III and IV Pancreatic Cancer That Cannot Be Removed by Surgery (NCT01098344)Cancer Research UK2010-04-01
Prospective Randomized Comparison of Bipolar Hemiarthroplasty and Total Hip Arthroplasty With Large Femoral Heads for the Treatment of Displaced Intracapsular Femoral Neck Fractures in the Elderly (NCT01109862)Wolfson Medical Center2010-04-01
IL-2 Expressing, Attenuated Salmonella Typhimurium in Unresectable Hepatic Spread (NCT01099631)Masonic Cancer Center, University of Minnesota2010-04-01
AZD9742 Single and Multiple Ascending Dose Study in Healthy Male and Female Japanese Subjects (NCT01114152)AstraZeneca2010-04-01
Therapeutic Effect of Quercetin and the Current Treatment of Erosive and Atrophic Oral Lichen Planus (NCT01375101)Mashhad University of Medical Sciences2010-04-01
A Study Of Neratinib (HKI-272) And Capecitabine In Japanese With Solid Tumor (NCT01128842)Puma Biotechnology, Inc.2010-04-01
Study of E3810 for Healthy Japanese Male (Under Fasting Condition) (NCT01085695)Eisai Co., Ltd.2010-04-01
Dexamethasone, Ofatumumab and Bendamustine (DOT) First-line in Mantle-cell Lymphoma(MCL) (NCT01221103)Southern Europe New Drug Organization2010-04-01
Entinostat and Clofarabine in Treating Patients With Newly Diagnosed, Relapsed, or Refractory Poor-Risk Acute Lymphoblastic Leukemia or Bilineage/Biphenotypic Leukemia (NCT01132573)National Cancer Institute (NCI)2010-04-01
31P MRS Ischaemic Exercise Optimisation and COPD (NCT01476072)GlaxoSmithKline2010-04-01
A Trial Investigating NN1218 in Subjects With Type 1 and Type 2 Diabetes (NCT01121276)Novo Nordisk A/S2010-04-01
Safety and Efficacy by Multiple Injection of KH902 in Patients With Diabetic Macular Edema (DME) (NCT01324869)Chengdu Kanghong Biotech Co., Ltd.2010-04-01
Intensive Management of Pressure and Volume Expansion in Patients With Subarachnoid Hemorrhage (NCT01414894)University of Washington2010-04-01
Partial Tear of Supraspinatus (SSP) and Treatment With Plasma Rich in Growth Factors (PRGF) (NCT01152658)Meir Medical Center2010-04-01
A Pilot Study for the Evaluation of Minocycline as a Microglia Inhibitor in the Treatment of Diabetic Macular Edema (NCT01120899)National Eye Institute (NEI)2010-04-01
Study of 0.1% Uracil Topical Cream (UTC) for the Prevention of Hand-Foot Syndrome (NCT01100463)Nanometics (d.b.a. PHD Biosciences)2010-04-01
Intraperitoneal RIT With 131I-8H9 for Pts With DSRCT and Other Solid Tumors Involving the Peritoneum (NCT01099644)Y-mAbs Therapeutics2010-04-01
MM-111 in Combination With Herceptin in Patients With Advanced Her2 Amplified, Heregulin Positive Breast Cancer (NCT01097460)Merrimack Pharmaceuticals2010-04-01
A Study to Investigate Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of BKM120 Plus GSK1120212 in Selected Advanced Solid Tumor Patients (NCT01155453)Novartis Pharmaceuticals2010-04-01
A Drug-Drug Interaction Study of the Effects of XL184 (Cabozantinib) on Rosiglitazone in Subjects With Solid Tumors (NCT01100619)Exelixis2010-04-01
Clinical Evaluation of Fluid Extract of Chamomilla Tincture for Oral Aphthae (NCT01122147)Mashhad University of Medical Sciences2010-04-01
Safety, Skin and Plasma Concentration of Azithromycin Dermal Formulation (NCT01243008)University of Zurich2010-04-01
E7080 (Lenvatinib) in Combination With Dacarbazine Versus Dacarbazine Alone as First Line Therapy in Patients With Stage IV Melanoma (NCT01133977)Eisai Inc.2010-04-01
A Pharmacokinetic Study of Levodopa and Carbidopa Intestinal Gel in Subjects With Advanced Parkinson's Disease (NCT01484990)AbbVie2010-04-01
Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of BMS-708163 (NCT01079819)Bristol-Myers Squibb2010-04-01
Bioequivalence Study of Sitagliptin/Metformin Combination Tablet (MK0431A-122) (NCT01093794)Merck Sharp & Dohme LLC2010-04-01
A Pharmacokinetic and Safety Study of IV Gallium Nitrate (Ganite) in Cystic Fibrosis Patients (NCT01093521)University of Washington2010-04-01
ONO-7746 Study in Healthy Adult Subject (NCT01106664)Ono Pharmaceutical Co., Ltd.2010-04-01
Mesenchymal Stem Cells; Donor and Role in Management and Reconstruction of Nonunion Fracture (NCT01626625)Indonesia University2010-04-01
Image-Guided Radiation Therapy for Bladder-Cancer Patients Undergoing Radiotherapy and Concurrent Gemcitabine Chemotherapy (NCT01104350)Memorial Sloan Kettering Cancer Center2010-04-01
Development of a Fast Measurement Technique of Insulin Resistance in Human (NCT01493934)Institut National de la Santé Et de la Recherche Médicale, France2010-04-01
Complications After Lower Third Molar Surgery (NCT03130933)University of Zagreb2010-04-01
A Study That Will Evaluate Ketogenesis and Glucose-Dependent Insulin Secretion Methodologies in Healthy Male Subjects (MK-0000-159)(COMPLETED) (NCT01055340)Merck Sharp & Dohme LLC2010-04-01
Cyclophosphamide, Alvocidib, and Rituximab in Treating Patients With High Risk B-Cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma (NCT01076556)National Cancer Institute (NCI)2010-04-01
Single-step Antigen Loading and TLR Activation of Dendritic Cells in Melanoma Patients (NCT01530698)Radboud University Medical Center2010-04-01
Dose Titration Investigation of the Pharmacokinetics of Testosterone Transdermal Systems in Hypogonadal Men (NCT01104246)Watson Pharmaceuticals2010-04-01
Radiation Dosimetry, Metabolism, Pharmacokinetics, Safety and Tolerability and PET Imaging With BAY94-9392 in Healthy Volunteers and Patients With Cancer or Inflammation (NCT01103310)Lantheus Biosciences Ltd.2010-04-01
Atazanavir/Ritonavir and Darunavir/Ritonavir PK Tail Study (NCT01073761)St Stephens Aids Trust2010-04-01
Knee Joint Icing and Knee-extension Strength (NCT01249612)Hvidovre University Hospital2010-04-01
Bioequivalence of Pramipexole Extended Release (PPX ER) 1.5mg x 1 Tablet Once Daily (q.d.) vs. PPX ER 0.375mg x 4 Tablets Under Fasted and Fed Conditions in Japanese Healthy Volunteers (NCT01119443)Boehringer Ingelheim2010-04-01
Ketamine for Low Mood States in the ER (NCT01209845)Yale University2010-04-01
A Multiple Dose Study of DWP05195 in Healthy Adult Subjects (NCT01094834)Daewoong Pharmaceutical Co. LTD.2010-04-01
A Safety Study of Dapivirine Vaginal Ring in Africa (NCT01071174)International Partnership for Microbicides, Inc.2010-04-01
Safety, Tolerability and Pharmacokinetic Profile of Levodopa Administered With Continuous Administration of ND0611 (NCT01103011)NeuroDerm Ltd.2010-04-01
Adenovirus Type 35 Based Circumsporozoite Malaria Vaccine in Burkina Faso (NCT01018459)National Institute of Allergy and Infectious Diseases (NIAID)2010-04-01
A Study To Assess The Pharmacokinetics, Safety, And Tolerability Of A Pregabalin Controlled Release Formulation Administered Following Various Sized Caloric Meals As Compared To The Pregabalin Immediate Release Formulation (NCT01080612)Pfizer's Upjohn has merged with Mylan to form Viatris Inc.2010-04-01
GABAergic Modulation in Pain Transmission in Human: Effect of the GABAA Agonist Clobazam on Peripheral and Central Sensitisation (NCT01291316)University Hospital, Geneva2010-04-01
Temsirolimus Plus Neratinib for Patients With Metastatic HER2-Amplified or Triple Negative Breast Cancer (NCT01111825)Puma Biotechnology, Inc.2010-04-01
AZD7687 Multiple Ascending Dose Study (NCT01119352)AstraZeneca2010-04-01
A Study to Assess the Safety and Immunogenicity of the Drug CAT-354 in Healthy Japanese Subjects (NCT01093040)MedImmune LLC2010-04-01
Simultaneous Integrated Boost (SIB) in Esophageal Cancer (NCT01102088)M.D. Anderson Cancer Center2010-04-01
Study of XPF-001 in the Treatment of Pain From Primary/Inherited Erythromelalgia (IEM) (NCT01090622)Xenon Pharmaceuticals Inc.2010-04-01
Study of Integrity of Down Inhibitor Bundle at Patients Suffering of Neuropathic Pain (NCT01053845)University Hospital, Clermont-Ferrand2010-04-01
A Study To Evaluate The Safety, Tolerability And Plasma Drug Levels Of PF-04447943 When Administered With Donepezil To Healthy Volunteer Subjects (NCT01097876)Pfizer2010-04-01
Effects of Traumeel®S Tablets on Exercise Induced Muscle Damage and Muscle Soreness (NCT01912469)Prof. Dr. med. Frank Christoph Mooren2010-04-01
Atopy Patch Test in Children With Food Allergy-related Gastrointestinal Symptoms (NCT01164293)Mahidol University2010-04-01
A Study to Evaluate the Safety of Tetravalent Rotavirus Vaccine in Healthy Indian Adult Male Volunteers (NCT01091298)Shantha Biotechnics Limited2010-04-01
A Phase 1 Study To Estimate The Relative Bioavailability Of Co-Administered Formulations Of Azithromycin Microsphere And Chloroquine Test Formulation Compared With Co-Administered Immediate Release Individual Azithromycin And Chloroquine Tablets In Healthy Adult Subjects (NCT01100060)Pfizer2010-04-01
A Study to Determine the Absorption of Peroral Insulin in Dextran Matrix (ORA3) (NCT01114750)Bows Pharmaceuticals AG2010-04-01
Autologous Fat Transfer for Scar Prevention and Remodeling (NCT01119326)University of Florida2010-04-01
Study on the Effects on Blood Glucose Following Intradermal and Subcutaneous Dosing of Insulin in Diabetic Patients (NCT01120444)Becton, Dickinson and Company2010-04-01
Phase I Study of Sulfatinib(HMPL-012) in Patients With Advanced Solid Tumors (NCT02133157)Hutchison Medipharma Limited2010-04-01
Safety, Tolerability, Pharmacodynamic and Pharmacokinetics of a Single Rectal Application of 10 mg NRL001 in Elderly Subjects (NCT01099683)Norgine2010-04-01
Endoscopic Resection of Gastric Subepithelial Masses, EndoResect Study (NCT01105728)Technical University of Munich2010-04-01
Relative Bioavailability of Pioglitazone After Co-administration With Different Doses of BI 10773 in Healthy Volunteers (NCT02172235)Boehringer Ingelheim2010-04-01
A Study to Evaluate Whether Food Has an Effect on the Uptake of Solifenacin and Tamsulosin When Administered in a Combination Tablet (NCT01953861)Astellas Pharma Europe B.V.2010-04-01
A Drug Interaction Study Evaluating GSK2248761 and Raltegravir Pharmacokinetics in Healthy Adult Subjects (NCT01101893)ViiV Healthcare2010-04-01
Everolimus, Bortezomib and/or Rituximab in Patients With Relapsed/Refractory Waldenstrom's Macroglobulinemia (NCT01125293)Dana-Farber Cancer Institute2010-04-01
Phase I/II Study To Test The Safety and Efficacy of TVI-Brain-1 As A Treatment For Recurrent Grade IV Glioma (NCT01081223)TVAX Biomedical2010-04-01
Pharmacokinetics and Safety Study of Apetrol ES (NCT02446353)LG Life Sciences2010-04-01
EXCEL: Change in Cardiometabolic Disease Risk Factors During an Interactive Fitness Program (NCT01104038)University of Massachusetts, Boston2010-04-01
Therapeutic Autologous Lymphocytes, Cyclophosphamide, and Aldesleukin in Treating Patients With Metastatic Melanoma (NCT01106235)Fred Hutchinson Cancer Center2010-04-01
First-in-Man, Dose-escalation Trial of c-Met Kinase Inhibitor EMD 1204831 in Subjects With Advanced Solid Tumors (NCT01110083)EMD Serono2010-04-01
A Study in Healthy Volunteers to Assess Safety and Blood Levels of AZD5847 After Multiple Doses Over 14 Days (NCT01116258)AstraZeneca2010-04-01
A Pilot Cross-over Bioequivalence Study of E3810 for Healthy Japanese Male (Under Postprandial Condition) (NCT01085708)Eisai Co., Ltd.2010-04-01
Pharmacokinetic Study of Spironolactone 25 mg, 50 mg and 100 mg Tablets (NCT01083290)Orion Corporation, Orion Pharma2010-04-01
Cholesterol Metabolism in Heterozygous Phytosterolemia (NCT01102647)University of Manitoba2010-04-01
Adriamycin, Vinblastine, DTIC and Revlimid in Elderly Hodgkin Lymphoma Patients (NCT01056679)University of Cologne2010-04-01
Mental Health Services for Toddlers in Foster Care (NCT01261806)University of Delaware2010-04-01
Clinical Trials to Compare Mosapride Bioavailability Between DWJ1252 and Mosapride Medicine (NCT01094847)Daewoong Pharmaceutical Co. LTD.2010-04-01
A First-Time-in-Human Study to Assess the Safety and Tolerability of PP 1420 in Healthy Subjects (NCT01052493)Imperial College London2010-04-01
A Study Evaluating IPI-926 in Combination With Gemcitabine in Patients With Metastatic Pancreatic Cancer (NCT01130142)Infinity Pharmaceuticals, Inc.2010-04-01
← Previous Next →

Track Phase 1 automatically

Every clearance here is in the API, with alerts when new ones post.